View Cart (0 items)

Pharmaceutical

Novartis plans $100 million research center in Shanghai

November 6, 2006
Swiss pharmaceutical company Novartis AG announced its plans for a US$100 million (euro78 million) integrated research and development center in Shanghai that will initially focus on cancers prevalent in China,
Read More

SEC probing insider trading before CNS, Glaxo deal

October 16, 2006
U.S. securities regulators said they are investigating possible insider trading in the call options of CNS Inc. before the October 9 announcement of its merger with GlaxoSmithKline, Reuters reports. U.S.
Read More

New Jersey judge dismisses 50 Vioxx suits

October 9, 2006
A New Jersey judge has dismissed about 50 Vioxx-related lawsuits against Merck & Co. filed in state court by British citizens, saying the cases should be heard in Britain, the
Read More

J&J CFO Darretta to retire

October 9, 2006
According to Reuters, diversified U.S. health care company Johnson & Johnson said that Robert Darretta, the company''s vice chairman and chief financial officer, will retire in early 2007. The company,
Read More

Court filings soar as Vioxx deadline looms

September 26, 2006
Fort Worth plaintiffs'' attorney John David Hart and other Texas lawyers will be making their way to the courthouse in the next few days to file additional Vioxx lawsuits before
Read More

Wyeth found not negligent in hormone drug trial

September 19, 2006
A jury in the first trial against Wyeth''s hormone replacement drug Prempro found that the company was not negligent and did adequately warn patients and doctors of the risk of
Read More

Adolor plunges as 2 out of 3 trials miss

September 5, 2006
Shares of Adolor Corp. lost more than half their value in early trading Tuesday as the drug maker and GlaxoSmithKline said two out of three clinical studies for their intestinal
Read More

Barr settles Novartis suit

June 14, 2006
The Associated Press reports that drug maker Barr Pharmaceuticals Inc. has agreed to pay $22.5 million to settle a lawsuit with a unit of Novartis, and said the payout will
Read More

Abbott accused of inflating drug prices

May 23, 2006
The Justice Department is accusing Abbott Laboratories of vastly inflating prices of its drugs as part of a fraudulent billing scheme alleged to have cost government health programs more than
Read More

Judge dismisses Merck shareholder suits

May 18, 2006
A federal judge has dismissed a group of shareholder lawsuits that charged Merck & Co. officers and directors with violating their duties by concealing the health risks of the company''s
Read More